Belgium
Tuberculosis profile
Population  2012 11 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.04 (0.039–0.04) 0.36 (0.35–0.36)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.04 (0.03–0.05)
Prevalence  (includes HIV+TB) 1.4 (0.56–2.6) 13 (5.1–24)
Incidence  (includes HIV+TB) 1.1 (0.94–1.2) 9.7 (8.5–11)
Incidence (HIV+TB only) 0.041 (0.036–0.046) 0.37 (0.32–0.42)
Case detection, all forms (%) 85 (75–97)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 235 (36) Relapse    
Smear-negative 216 (33) Treatment after failure    
Smear-unknown / not done 21 (3) Treatment after default    
Extrapulmonary 179 (27) Other 78 (100)
Other 0 (0)      
Total new 651   Total retreatment 78  
           
Other (history unknown) 258        
Total new and relapse 651   Total cases notified 987  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.6 1.8 1.5
Age < 15 8 33 16
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 77   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 84  
Retreatment 61  
TB/HIV 2012 Number (%)
TB patients with known HIV status 556 (56)
HIV-positive TB patients 43 (8)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.3 (0.54–2.7) 11 (3.2–27)
MDR-TB cases among notified pulmonary
TB cases
6 (3–13) 9 (3–21)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 503 (95%) 53 (68%) 735
Laboratory-confirmed MDR-TB cases 8 7 20
Patients started on MDR-TB treatment     20
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-24 Data: www.who.int/tb/data